WealthBridge Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.32M | Buy |
13,209
+89
| +0.7% | +$19.1K | 0.66% | 30 |
|
|
2026
Q1 | $2.85M | Buy |
13,120
+85
| +0.7% | +$18.9K | 0.66% | 32 |
|
|
2025
Q4 | $2.98M | Sell |
13,035
-57
| -0.4% | -$13K | 0.68% | 33 |
|
|
2025
Q3 | $3.03M | Buy |
13,092
+292
| +2% | +$59.5K | 0.71% | 33 |
|
|
2025
Q2 | $2.38M | Buy |
12,800
+262
| +2% | +$48.7K | 0.6% | 41 |
|
|
2025
Q1 | $2.63M | Sell |
12,538
-35
| -0.3% | -$6.8K | 0.74% | 29 |
|
|
2024
Q4 | $2.23M | Buy |
12,573
+317
| +3% | +$58.3K | 0.62% | 39 |
|
|
2024
Q3 | $2.42M | Buy |
12,256
+972
| +9% | +$181K | 0.69% | 33 |
|
|
2024
Q2 | $1.94M | Sell |
11,284
-243
| -2% | -$40.3K | 0.64% | 37 |
|
|
2024
Q1 | $2.1M | Sell |
11,527
-9
| -0.1% | -$1.55K | 0.71% | 34 |
|
|
2023
Q4 | $1.79M | Sell |
11,536
-20
| -0.2% | -$2.92K | 0.67% | 36 |
|
|
2023
Q3 | $1.72M | Sell |
11,556
-215
| -2% | -$31.6K | 0.71% | 32 |
|
|
2023
Q2 | $1.59M | Buy |
11,771
+61
| +0.5% | +$8.95K | 0.63% | 34 |
|
|
2023
Q1 | $1.87M | Buy |
11,710
+180
| +2% | +$27.5K | 0.74% | 33 |
|
|
2022
Q4 | $1.86M | Buy |
11,530
+454
| +4% | +$69.6K | 0.78% | 32 |
|
|
2022
Q3 | $1.7M | Hold |
11,076
| – | – | 0.72% | 32 |
|
|
2022
Q2 | $1.7M | Buy |
11,076
+358
| +3% | +$54.7K | 0.72% | 32 |
|
|
2022
Q1 | $1.74M | Buy |
10,718
+756
| +8% | +$110K | 0.65% | 33 |
|
|
2021
Q4 | $1.35M | Buy |
9,962
+53
| +0.5% | +$6.26K | 0.5% | 46 |
|
|
2021
Q3 | $1.07M | Buy |
9,909
+44
| +0.4% | +$5.03K | 0.4% | 53 |
|
|
2021
Q2 | $1.11M | Sell |
9,865
-97
| -1% | -$10.9K | 0.4% | 54 |
|
|
2021
Q1 | $1.08M | Buy |
9,962
+50
| +0.5% | +$5.35K | 0.44% | 52 |
|
|
2020
Q4 | $1.06M | Buy |
9,912
+4
| +0% | +$384 | 0.46% | 50 |
|
|
2020
Q3 | $868K | Buy |
9,908
+103
| +1% | +$9.7K | 0.45% | 50 |
|
|
2020
Q2 | $963K | Buy |
9,805
+207
| +2% | +$18.2K | 0.55% | 43 |
|
|
2020
Q1 | $731K | Sell |
9,598
-123
| -1% | -$10.5K | 0.51% | 48 |
|
|
2019
Q4 | $861K | Buy |
9,721
+28
| +0.3% | +$2.33K | 0.56% | 48 |
|
|
2019
Q3 | $734K | Sell |
9,693
-397
| -4% | -$27.2K | 0.53% | 47 |
|
|
2019
Q2 | $930K | Sell |
10,090
-220
| -2% | -$17.3K | 0.85% | 33 |
|
|
2019
Q1 | $803K | Buy |
10,310
+220
| +2% | +$18K | 0.51% | 41 |
|
|
2018
Q4 | $930K | Buy |
+10,090
| New | +$887K | 0.71% | 33 |
|
Other funds holding ABBV
WealthBridge Capital Management's ABBV Position: Q2 2026 in Review
WealthBridge Capital Management increased its AbbVie (ABBV) stake by 0.68% in Q2 2026, buying an estimated $19.1K and bringing the position to 13,209 shares worth $3.32M. The position accounts for 0.66% of the portfolio, ranked #30.
WealthBridge Capital Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- WealthBridge Capital Management held 13,209 shares of AbbVie worth $3.32M as of Q2 2026.
- WealthBridge Capital Management bought 89 AbbVie shares in Q2 2026, an estimated $19.1K.
- AbbVie made up 0.66% of WealthBridge Capital Management's portfolio in Q2 2026, its #30 holding.
- WealthBridge Capital Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on WealthBridge Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.